Skip to main content
Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
22.19
+0.29 (1.32%)
At close: May 17, 2024, 11:17 AM
21.26
-0.93 (-4.19%)
After-hours: May 17, 2024, 4:06 PM EDT

CALT Revenue

In the year 2023, Calliditas Therapeutics AB (publ) had annual revenue of $119.73M with 55.09% growth.

Revenue (ttm)
$119.73M
Revenue Growth
+55.09%
P/S Ratio
4.91
Revenue / Employee
$551,756
Employees
217
Market Cap
588.25M USD

Revenue Chart

* The company reports in SEK currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023119.73M42.53M55.09%
Dec 31, 202277.20M51.72M202.95%
Dec 31, 202125.48M25.38M23,808.62%
Dec 31, 2020106.59K-19.77M-99.46%
Dec 31, 201919.87M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetIQ 1.12B
Accolade 414.29M
GeneDx Holdings 221.85M
Valneva SE 166.26M
Harrow Health 138.68M
Avid Bioservices 136.74M
Taysha Gene Therapies 14.16M
Revenue Rankings

CALT News

More News